Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Two Way Crossover Closed Loop MPC vs Control IQ

NCT: NCT05799781 · COMPLETED

NCT IDNCT05799781
StatusCOMPLETED
Start Date2023-03-13
Completion2025-01-28
SponsorOregon Health and Science University (OTHER)
First posted
Last updated

Brief Summary

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the amount of meal insulin that will be dosed and deliver that insulin. The investigators will test how well the new algorithm manages glucose compared to the participant's usual care including the tslim X2 pump with Control IQ enabled. This type of algorithm may improve glucose control for high risk patient populations.

Frequently Asked Questions

What is Two Way Crossover Closed Loop MPC vs Control IQ?

Two Way Crossover Closed Loop MPC vs Control IQ is a clinical trial registered under NCT05799781. Current status: COMPLETED.

What is the status of NCT05799781?

The current status of NCT05799781 (Two Way Crossover Closed Loop MPC vs Control IQ) is: COMPLETED.

When did Two Way Crossover Closed Loop MPC vs Control IQ start?

Two Way Crossover Closed Loop MPC vs Control IQ started on 2023-03-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.